申请人:Hangzhou Innogate Pharma Co., Ltd.
公开号:US11225492B2
公开(公告)日:2022-01-18
The present invention provides compounds of Formula (I), and the pharmaceutically acceptable salts, hydrates, and solvates thereof. It also provides pharmaceutical compositions, preparation and utilities thereof in treating diseases and disorders including cancers.
本发明提供了式(I)化合物及其药学上可接受的盐、水合物和溶液。本发明还提供了用于治疗包括癌症在内的疾病和失调的药物组合物、制备方法和用途。